Fortress Biotech Inc (NASDAQ:FBIO)
| 0.5313 Delayed Data As of May 26 |  +0.0581 / +11.84%Today’s Change | 0.48 Today|||52-Week Range 1.33 | -18.89% Year-to-Date |
Latest FBIO News | Press Releases
No recent news for Fortress Biotech Inc.
Today’s Trading
| Previous close | 0.49 |
| Today’s open | 0.49 |
| Day’s range | 0.49 - 0.56 |
| Volume | 1,259,923 |
| Average volume (3 months) | 670,728 |
| Market cap | $73.7M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -22.99% |
| Earnings growth (this year) | +26.39% |
| Earnings growth (next 5 years) | +28.20% |
| Revenue growth (last year) | +10.11% |
| P/E ratio | NM |
| Price/Sales | 0.77 |
| Price/Book | 1.45 |
Competitors
Data as of 3:57pm ET, 05/26/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $75.7M |
| Annual profit (last year) | -$86.6M |
| Net profit margin | -114.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bay Harbor Islands, Florida |
Forecasts
